Minimize Uncertainty – Make Informed Decisions – Succeed

Artificial_Intelligence

AI in Healthcare and Digital Health Today—January 19, 2026

January 19, 2026Merge Labs,Claude for Healthcare,Google,Wearlinq eWave,BioPharma and Tech News,LabSafety Bench,Anthropic,Google Gemini,LG CNS,CHA Biotech,OpenAI,Bristol Myers Squibb,AI in Healthcare and Digital Health,ChatGPT Health,Vista AI,Withings,ImmunaiUltrahuman,Click Therapeutics

This week's AI in Healthcare and Digital Health update highlights rapid…

by Timos Papagatsias

Oncology News

Oncology Video Recap—January 19, 2026

January 19, 2026Eureka,Tahoe Therapeutics,bayer,Alloy Therapeutics,pfizer,HER2-mutant non-small cell lung cancer,BioPharma and Tech News,ER-positive/HER2-negative metastatic breast cancer,Pancreatic cancer,BRAF V600E metastatic colorectal cancer,Ivonescimab,testicular germ cell tumor,Akeso,Sevabertinib,Merck KGaA,Hyrnuo,Oncology News,(Z)-Endoxifen,hepatocellular carcinoma,CPI-008,Encorafenib,cRGD-ZW800-1,Cetuximab,BRAFTOVI,Atossa,FOLFIRI,CuradelPimicotinib,Summit

In this week's Oncology update regulatory milestones and late-stage clinical…

by LucidQuest

Hematology

Hematology Today—January 19, 2026

January 19, 2026BioPharma and Tech News,hemophilia bnivolumab,Acute Myeloid Leukemia,Hematology News,venetoclax,essential thrombocythemia,PharmaEssentia,Diffuse large B-cell lymphoma,ropeginterferon alfa-2b-njft,epcoritamab

This week's Hematology update spans regulatory milestones, late-stage clinical…

by LucidQuest

Onco_background

Oncology Today—January 19, 2026

January 19, 2026astrazeneca,BioPharma and Tech News,EGFR-mutated NSCLC,Orphan Drug Designation,immuno-oncology,Oncology News,antibody-drug conjugates,Non-small cell lung cancer,CAR T cell therapySummit Therapeutics,FDA regulatory filings

This week's Oncology roundup covers regulatory approvals and filings,…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Signet Therapeutics RMB 80 million Series A for organoids + AI in oncology

January 19, 2026Oncology,clinical trials,orphan drug,biopharma,Organoids,Lucid Diligence Brief,diligence,AI in drug discovery,China biotech,financing,FDA fast trackTEAD inhibitors

Lucid Diligence Brief: Signet Therapeutics RMB 80 million Series A for…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: AstraZeneca to acquire Modella AI

January 18, 2026Oncology,clinical trials,Regulatory,AI in healthcare,biopharma,digital pathology,Biomarkers,Lucid Diligence Brief,payer access,diligenceR&D operations

Lucid Diligence Brief: AstraZeneca to acquire Modella AI Professional audiences…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Cytotheryx $60 million Series A in liver cell therapy

January 17, 2026market access,Regulatory,Cell Therapy,biopharma,Lucid Diligence Brief,hepatology,diligence,fundraising,venture financing,manufacturingclinical translation

Lucid Diligence Brief: Cytotheryx $60 million Series A in liver cell therapy…

by Timos Papagatsias

Public_Health

Public Health Video Recap—January 16, 2026

January 16, 2026Alzheimer’s diagnostics.,regenerative medicine,Depression,BioPharma and Tech News,Obesity Treatment,Osteoarthritis,Public Health News,GLP-1 agonists,15-PGDH,alcohol carcinogenicity,RSVpreF vaccine,maternal immunization,exercise therapydeforestation,vector-borne disease

This Public Health video recap highlights major population health and…

by LucidQuest

Public_Health

Public Health Today—16 January, 2026

January 16, 2026STD,Medicare,BioPharma and Tech News,Microplastics,UK Biobank,BGI Genomics,Public Health News,Roche Diagnostics,American Cancer Society,Cancer Statistics 2026,JAMA,CNS-active medications,Cochrane ReviewSalk Institute,Alzheimer’s blood tests

This week's Public Health update spotlights major population health and…

by LucidQuest

Respiratory

Respiratory Today—January 16, 2026

January 16, 2026Tessera Therapeutics,Kinaset Therapeutics,GRI Bio,AN2 Therapeutics,cystic fibrosis,Mycobacterium abscessus Infection,Traws Pharma,BioPharma and Tech News,STAT3,Bronchiectasis,IL-11,Boehringer Ingelheim,iNKT cells,Idiopathic Pulmonary Fibrosis,CFTR,Krystal Biotech,PDE3-PDE4 inhibitors,Respiratory News,Capsid endonuclease inhibitors,chronic obstructive pulmonary disease,3CL protease inhibitors,JAK inhibitors,Gene writing,Agomab,TPRT,ALK5,Biofilm formation,TGF beta,Tvardi Therapeutics,severe asthma,Clarametyx BiosciencesAlpha-1 antitrypsin deficiency,AirNexis Therapeutics

This week's respiratory update highlights continued momentum across pulmonary…

by LucidQuest

Vaccines

Vaccines Today—January 16, 2026

January 16, 2026AIM Vaccine,Rabies,Moderna,PanChol,BioPharma and Tech News,diploid rabies vaccine,Spikevax,Human Metapneumovirus,mResvia,Parainfluenza Virus Type 3,Transgene,pembrolizumab,Vaccine news,head and neck squamous cell carcinoma,cholera,castlevax,respiratory syncytial virus,Mass General BrighamClover Biopharmaceuticals,AptarGroup

This week's Vaccines update highlights recent progress across vaccines and…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Ocugen preliminary Phase 2 data in geographic atrophy

January 16, 2026clinical trials,market access,gene therapy,Regulatory,ophthalmology,biopharma,Lucid Diligence Brief,payer access,diligence,Geographic atrophyretina surgery

Lucid Diligence Brief: Ocugen preliminary Phase 2 data in geographic atrophy…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.